Article: Endocardial Solutions Reports Third Quarter Results.

MINNEAPOLIS/ST. PAUL, Minn., Oct. 21 /PRNewswire/ -- Endocardial Solutions, Inc. (Nasdaq: ECSI) today reported financial results for the third quarter ended September 30, 1998. Revenues were $692,996. The net loss for the third quarter was $2,418,816, or $.27 per share, compared with a net loss of $2,182,974, or $.25 per share, for the same period in 1997.

"Our third quarter results show three important trends as we move from a research and development company to a commercial company," said Jim Bullock, president and CEO. "First, our European full market release through Medtronic, Inc. (NYSE: MDT) accounted for our increased revenue over second quarter. ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!